$12,799.00
Tanrecta is intended for the treatment of late-stage non-small cell lung cancer with metastases caused by a mutation in the gene responsible for the production of the MET enzyme – in adults over 18 years of age.
Active ingredient: capmatinib
Prescription medicine
| Дозировка | 150 Mg, 200 Mg |
|---|
